Company Filing History:
Years Active: 2017-2020
Title: Georgy Mikhaylov: Innovator in Diagnostic Compounds
Introduction
Georgy Mikhaylov is a notable inventor based in Almaty, Kazakhstan. He has made significant contributions to the field of diagnostic compounds, particularly in relation to inflammatory and neoplastic diseases. With a total of 2 patents, Mikhaylov's work is paving the way for advancements in medical diagnostics.
Latest Patents
Mikhaylov's latest patents include innovative Cathepsin-binding compounds bound to a carrier. These compounds comprise a diagnostic moiety for use in the diagnosis of inflammatory diseases and neoplastic diseases. The Cathepsin-binding compound is designed to bind to inflammatory cells of the tumor stroma. Additionally, his inventions also encompass Cathepsin B-targeting compounds and Cathepsin B-binding and liposome-binding compounds.
Career Highlights
Throughout his career, Mikhaylov has worked with esteemed organizations such as the J. Stefan Institute and Schaschke, Norbert. His experience in these institutions has contributed to his expertise in the development of diagnostic compounds.
Collaborations
Mikhaylov has collaborated with notable individuals in his field, including Olga Vasiljeva and Boris Turk. These partnerships have further enhanced his research and innovation capabilities.
Conclusion
Georgy Mikhaylov's contributions to the field of diagnostic compounds are significant and impactful. His innovative patents and collaborations reflect his dedication to advancing medical diagnostics.